Faculty

Institution

Unit

Venue

Corinne Linardic

Duke University

Affiliations

School of Medicine

Clinical Science Departments

Department of Pediatrics

Division of Hematology-Oncology

NoneCorinne Linardic is currently serving as a Clinical Science S faculty at Duke University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Corinne Linardic

Duke University

You can click a keyword to filter the displayed items

oncology cancer biology cancer research tumor biology cancer genetics genetics medicinal research molecular cancer cancer genomics gene expression cancer care oncogenes cell biology cancer treatment medicine tumor targeting pediatrics cancer growth cancer cells cancer immunotherapy medical genetics genomics sarcoma cellular therapy cell signaling anti-cancer agents hematological malignancies protein science genome biology cancer imaging leukemia molecular cell biology surgical oncology embryonal rhabdomyosarcoma cancer management cell regulation pharmacotherapy cellular biology signaling pathways drug targeting oncogenic agent cell death cell research stem cell research apoptosis clinical medicine cellular senescence gene regulation gene function genetic modeling fusion-negative rhabdomyosarcoma genomic classification lipid science lipoprotein metabolism baseline correction genetic basis epigenomics cell growth clinical mycology host factors mutagenesis conformational studies molecular evidence protein genetics sphingolipid breakdown products tumor-suppressor lipids rhabdomyosarcoma research clinical outcome international consortium hippo pathway suppression regional tumor heterogeneity dynamic cell movements tumor-propagating cells normal human cells genetic events tumorigenic state

Notable Scholarly Works

Notable Federal Grants

Collaborators

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma. UNC Libraries (2026)

oncogenespathologybiological advancestumor biologymalignant diseasesarcomacancer researchcancer cellsoncology

Abstract 1092: Runx2 Inhibition Alters Pax3:: Foxo1 Driven Fusion-Positive Rhabdomyosarcoma Cell State and Growth. Cancer Research (2024)

Elizabeth A. MendesAudrey L. ChambersSamantha J. WeitzelMichael DeelAanandi MunshiChristopher M. CounterSeth ZimmermanJohn BushwellerCorinne M. Linardic

oncogenesradiation oncologytumor targetingtumor biologyanti-cancer agentscancer immunotherapycancer treatmentmedicinal researchcancer researchcancer growthpharmacologymedicineclinical researchcancer cellsenzyme inhibitioncancer careoncologycancer biology

Abstract 134: Zeb2 as a Therapeutic Target in Fusion-Positive Rhabdomyosarcoma. Cancer Research (2024)

Assil FahsAanandi MunshiLeen BarbarSeth ZimmermanChris CounterCorinne Linardic

radiation oncologycancer caretumor targetinganti-cancer agentssarcomamedicinal researchsurgical oncologymolecular cancerfusion-positive rhabdomyosarcomacancer researchpharmacologytherapeutic targetsclinical researchcancer treatmentcancer geneticshealth sciencesoncologycancer biology

Abstract 5960: Targeting Cdk8: A Translatable Therapeutic Approach for Fusion-Positive Arms. Cancer Research (2024)

Susu ZhangClare MaloneBrian GuedesKathleen EngelMarissa JustKenneth RossAssil FahsGiulia DigiovanniDiyana GranumRex BentleyLeen BarbarChristian Cerda-SmithElizabeth MendesOzgun ErdoganAlexander KovachKristianne OristianSeth ZimmermanJack F. ShernKris WoodChris CounterCorinne M. LinardicKimberly Stegmaier

oncogenescrispr knockoutradiation oncologytumor biologydruggable dependenciescell biologymolecular cancercarcinogenesistumor suppressorsoncogenic agentabstract 5960systems biologycancer cellscancer geneticscancer biology

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma. JAMA Network Open (2024)

Bailey A. Martin-GiacaloneHe LiMichael E. ScheurerDana L. CaseyShannon Dugan-PerezDeborah A. Marquez-DoDonna MuznyRichard A. GibbsDonald A. BarkauskasDavid HallDouglas R. StewartJoshua D. SchiffmanMatthew T. McEvoyJaved KhanDavid MalkinCorinne M. LinardicBrian D. CromptonJack F. ShernStephen X. SkapekRajkumar VenkatramaniDouglas S. HawkinsAniko SaboSharon E. PlonPhilip J. Lupo

pediatricssurvival outcomesmedical geneticsgermline genetic testingoncologygenetics

Roadmap for the Next Generation of Children’s Oncology Group Rhabdomyosarcoma Trials. Cancer (2024)

Jonathan L. MettsJamie M. AyeJacquelyn N. CraneSapna OberoiFrank M. BalisSmita BhatiaKira BonaBruce CarletonRoshni DasguptaFilemon S. Dela CruzKatie A. GreenzangJonathan L. KaufmanCorinne M. LinardicSusan K. ParsonsMark Robertson‐TessiErin R. RudzinskiAlice SoragniElizabeth StewartBrenda J. WeigelSuzanne L. WoldenAaron R. WeissRajkumar VenkatramaniChristine M. Heske

cancer researchmedicinecancer treatmentclinical trialsoncology

Spontaneous Expression of the Cic:: Dux4 Fusion Oncoprotein From a Conditional Allele Potently Drives Sarcoma Formation in Genetically Engineered Mice. Oncogene (2024)

Peter G. HendricksonKristianne M. OristianMaKenna R. BrowneLixia LuoYan MaDiana M. CardonaJoshua O. NashPedro L. BallesterScott DavidsonAdam ShlienCorinne M. LinardicDavid G. Kirsch

oncogenesgenetic engineeringsarcomaconditional allelefusionspontaneous expressionbiomedical engineeringsarcoma formationmolecular biologycancer geneticsgenetics

Abstract 3534: Interrogating the Immune Microenvironment of a Novel Mouse Model of Fusion Positive Rhabdomyosarcoma. Cancer Research (2023)

Erin E. ReschKristianne M. OristianElizabeth MendesCorinne M. LinardicBrian H. Ladle

pathologynovel mouse modelimmunologymedicinal researchcancer researchimmune microenvironmentfusion positive rhabdomyosarcomahealth sciencesoncologycancer biology

Abstract Sy23-03: Rhabdomyosarcoma: New Research Tools for Precision Medicine. Cancer Research (2023)

Corinne Mary Linardic

cancer research

Children's Oncology Group's 2023 Blueprint for Research: Soft Tissue Sarcomas. Pediatric Blood & Cancer (2023)

Sapna OberoiJacquelyn N. CraneJosephine H. HaduongErin R. RudzinskiSuzanne L. WoldenRoshni DasguptaCorinne M. LinardicAaron R. WeissRajkumar Venkatramani

pediatricsoncologysoft tissue sarcomas

1
2
3
4
5
9
10 / page

Corinne Linardic

Duke University

Affiliations

School of Medicine

Clinical Science Departments

Department of Pediatrics

Division of Hematology-Oncology

NoneCorinne Linardic is currently serving as a Clinical Science S faculty at Duke University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Corinne Linardic

Duke University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma. UNC Libraries (2026)

oncogenespathologybiological advancestumor biologymalignant diseasesarcomacancer researchcancer cellsoncology

Abstract 1092: Runx2 Inhibition Alters Pax3:: Foxo1 Driven Fusion-Positive Rhabdomyosarcoma Cell State and Growth. Cancer Research (2024)

Elizabeth A. MendesAudrey L. ChambersSamantha J. WeitzelMichael DeelAanandi MunshiChristopher M. CounterSeth ZimmermanJohn BushwellerCorinne M. Linardic

Abstract 134: Zeb2 as a Therapeutic Target in Fusion-Positive Rhabdomyosarcoma. Cancer Research (2024)

Assil FahsAanandi MunshiLeen BarbarSeth ZimmermanChris CounterCorinne Linardic

Abstract 5960: Targeting Cdk8: A Translatable Therapeutic Approach for Fusion-Positive Arms. Cancer Research (2024)

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma. JAMA Network Open (2024)

pediatricssurvival outcomesmedical geneticsgermline genetic testingoncologygenetics

Roadmap for the Next Generation of Children’s Oncology Group Rhabdomyosarcoma Trials. Cancer (2024)

cancer researchmedicinecancer treatmentclinical trialsoncology

Spontaneous Expression of the Cic:: Dux4 Fusion Oncoprotein From a Conditional Allele Potently Drives Sarcoma Formation in Genetically Engineered Mice. Oncogene (2024)

Peter G. HendricksonKristianne M. OristianMaKenna R. BrowneLixia LuoYan MaDiana M. CardonaJoshua O. NashPedro L. BallesterScott DavidsonAdam ShlienCorinne M. LinardicDavid G. Kirsch

oncogenesgenetic engineeringsarcomaconditional allelefusionspontaneous expressionbiomedical engineeringsarcoma formationmolecular biologycancer geneticsgenetics

Abstract 3534: Interrogating the Immune Microenvironment of a Novel Mouse Model of Fusion Positive Rhabdomyosarcoma. Cancer Research (2023)

Erin E. ReschKristianne M. OristianElizabeth MendesCorinne M. LinardicBrian H. Ladle

pathologynovel mouse modelimmunologymedicinal researchcancer researchimmune microenvironmentfusion positive rhabdomyosarcomahealth sciencesoncologycancer biology

Abstract Sy23-03: Rhabdomyosarcoma: New Research Tools for Precision Medicine. Cancer Research (2023)

Corinne Mary Linardic

cancer research

Children's Oncology Group's 2023 Blueprint for Research: Soft Tissue Sarcomas. Pediatric Blood & Cancer (2023)

Sapna OberoiJacquelyn N. CraneJosephine H. HaduongErin R. RudzinskiSuzanne L. WoldenRoshni DasguptaCorinne M. LinardicAaron R. WeissRajkumar Venkatramani

pediatricsoncologysoft tissue sarcomas

1
2
3
4
5
9
10 / page

Similar Faculty Members

Dean W. Felsher

Institution

Stanford University

oncology

cancer research

Wael El-Rifai

Institution

University of Miami

molecular cancer

cancer biology

Craig Horbinski

Institution

Northwestern University

neuro-oncology

oncology

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Chellappan, Srikumar

Institution

University of South Florida

cell biology

tumor biology

Eric J. Stanbridge

Institution

University of California, Irvine

genetics

cancer biology

James Olson

Institution

University of Washington

brain tumor research

anti-cancer agent

Daniel Brat

Institution

Northwestern University

oncology

brain tumor research

Edward Gabrielson

Institution

Johns Hopkins University

oncology

cancer research

C James

Institution

Northwestern University

oncology

brain tumor research

Similar Faculty Members

Dean W. Felsher

Institution

Stanford University

oncology

cancer research

Wael El-Rifai

Institution

University of Miami

molecular cancer

cancer biology

Craig Horbinski

Institution

Northwestern University

neuro-oncology

oncology

Jonathan D Licht

Institution

University of Florida

oncology

pathology

Chellappan, Srikumar

Institution

University of South Florida

cell biology

tumor biology

Eric J. Stanbridge

Institution

University of California, Irvine

genetics

cancer biology

James Olson

Institution

University of Washington

brain tumor research

anti-cancer agent

Daniel Brat

Institution

Northwestern University

oncology

brain tumor research

Edward Gabrielson

Institution

Johns Hopkins University

oncology

cancer research

C James

Institution

Northwestern University

oncology

brain tumor research